Both in Pharmaceuticals
Aptevo Therapeutics vs Jupiter Neurosciences
Over the past year APVO returned −92.8% and JUNS returned −98.1%; their daily moves had a correlation of -0.02.
APVO −92.8% JUNS −98.1%Growth of $1, one year, split-adjusted
| Metric | APVO | JUNS |
|---|---|---|
| Price | $1.86 | $2.58 |
| Market cap | $3.4M | $3.4M |
| Today | −2.62% | +2.79% |
| 1 month | −21.4% | −38.3% |
| 6 months | −53.0% | −89.4% |
| Year to date | −80.3% | −96.6% |
| 1 year | −93.1% | −97.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 86.9% |
| Net margin | — | −9380.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 52.6× |
| Net cash | $9.8M | -$6.6K |
| Dividend yield | — | — |
| Volatility (60d) | 115.8% | 1,269.4% |
| Short % of float | 15.9% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).